Avid Bioservices Inc (CDMO)

[ststephensrevenge]

In the event the FDA comes back with a favorable ruling on the Cotara phase III protocol, why not outright sell the entire Cotara platform and "threaten" to take Bavi to the finish line solo for 2nd Line NSCLC with the proceeds if the MOS is impressive.

Then the $1.5 - $2.5B valuations being thrown around have some vailidity. BP isn't in any hurray to throw out any fair offers knowing Peregrine doesn't have the financial means to call BP's bluff.

Throw in some favorable preliminary Pancreatic and Liver results and this armpit market cap that we currently sit at will finally seem like a bad dream in our rear view mirror.